About this digest
About Prescribed Sermorelin
A charted reading of the sermorelin literature — mapped, cited, and honest about where the road runs out.
What this site is
Think of Prescribed Sermorelin as a cartographer's survey of the published sermorelin research — a route drawn across the peer-reviewed literature, waypoint by waypoint, so a non-specialist can follow where the evidence actually leads. No treatment is offered here and none is possible: nothing on these pages diagnoses, prescribes, or counsels anyone on a personal health decision, and no dose is ever recommended. Reading and charting the record is the whole of the work; supplying, sourcing, or dispensing sermorelin is not something this survey does or could do, and there is no clinician on the masthead to consult.
We approach the literature the way a careful travel writer approaches a route — charting where the signal goes, what each study actually measured, and where the road honestly runs out of pavement. Every quantitative claim on the site is tied to a numbered source on the references page.
About the name
The word "prescribed" in our name is editorial framing, not a service claim. It points to sermorelin's documented prescribing history — formerly FDA-approved as a pediatric growth-hormone-deficiency drug (NDA 020443), withdrawn from the US market in 2008 for commercial rather than safety reasons, and now prepared by compounding pharmacies. It is the provenance register of the literature we read, not an offer of a prescription, a consultation, or a treatment. This site does not and cannot prescribe anything.
How we handle the evidence
We separate what was shown from what is hoped. We attribute adult body-composition and cognition findings to the stabilized analog (tesamorelin) that produced them rather than transferring them to native sermorelin. We state plainly where the data are thin — particularly for long-term adult anti-aging use — and we flag the caveats regulators have raised. We do not recommend doses for any individual. Doses that appear on the sermorelin dosage in the literature page are reported strictly as study parameters: an amount, a population, a route. When in doubt, we mark the limit rather than fill it.